The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Orally disintegrating films: A modern expansion in drug delivery system
Open accessAbstract
Over the past few decades, tendency toward innovative drug delivery systems has majorly increased attempts to ensure efficacy, safety and patient acceptability. As discovery and development of new chemical agents is a complex, expensive and time consuming process, so recent trends are shifting toward designing and developing innovative drug delivery systems for existing drugs. Out of those, drug delivery system being very eminent among pediatrics and geriatrics is orally disintegrating films (ODFs). These fast disintegrating films have superiority over fast disintegrating tablets as the latter are associated with the risks of choking and friability. This drug delivery system has numerous advantages over conventional fast disintegrating tablets as they can be used for dysphasic and schizophrenic patients and are taken without water due to their ability to disintegrate within a few seconds releasing medication in mouth. Various approaches are employed for formulating ODFs and among which solvent casting and spraying methods are frequently used. Generally, hydrophilic polymers along with other excipients are used for preparing ODFs which allow films to disintegrate quickly releasing incorporated active pharmaceutical ingredient (API) within seconds. Orally disintegrating films have potential for business and market exploitation because of their myriad of benefits over orally disintegrating tablets. This present review attempts to focus on benefits, composition, approaches for formulation and evaluation of ODFs. Additionally, the market prospect of this innovative dosage form is also targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Formulation and Evaluation of Fast Dissolving Films for Delivery of Triclosan to the Oral Cavity
Dinge, A., & Nagarsenker, M. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9047-7 · Cited by 220
Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease
Liew, K. B., Tan, Y. T. F., & Peh, K. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9729-4 · Cited by 129
Characterization and Optimization of Orodispersible Mosapride Film Formulations
ElMeshad, A. N., & El‐Hagrasy, A. S. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9713-z · Cited by 99
Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate
Preis, M., Pein‐Hackelbusch, M., & Breitkreutz, J. (2012) · Pharmaceutics · doi:10.3390/pharmaceutics4040551 · Cited by 97
Ammar, H. O., Ghorab, M., El-Nahhas, S. A., & Kamel, R. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-008-9167-0 · Cited by 89
Juliano, C., Cossu, M., Pigozzi, P., et al. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9153-6 · Cited by 76
Cited by
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
Rampedi, P. N., Ogunrombi, M. O., & Adeleke, O. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060712 · Cited by 15
Human Oropharyngeal Candidiasis: From Etiology to Current Treatment
Qadir, M. I., Bashir, H., & Ahmad, M. H. (2023) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023049730 · Cited by 8
Self-citation
Metadata
- Authors
- Irfan, M., Rabel, S., Bukhtar, Q., Qadir, M. I., Jabeen, F., & Khan, A.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2016-09
- Volume
- 24
- Issue
- 5
- Pages
- 537-546
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W2047286887
- Cited by
- 361
- References
- 6
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.